Drug Screening at Single-Organoid Resolution via Bioprinting and Interferometry

Researchers presented a pipeline to generate bioprinted tumor organoids linked to label-free, time-resolved imaging via high-speed live cell interferometry and machine learning-based quantitation of individual organoids.